2 unknown, 1 completed, 1 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Recruiting 1 |
Follow Mirabegron 50 MG: new trials by email Literature Review of Mirabegron 50 MG trials Research Report on Mirabegron 50 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) Mirabegron 50 MG, Oxybutynin Chloride 5 MG - Overactive Bladder | Phase 2 | Unknown | Seoul National University Hospital | 44 | 2024-04-01 | 2024-03-08 |
| Using Mirabegron to Increase BP in Patients With POTS Mirabegron 50 MG, Mirabegron 25 MG - Postural Orthostatic Tachycardia Syndrome, Chronic Orthostatic Intolerance | Phase 2 | Completed | Cedars-Sinai Medical Center | 20 | 2023-12-22 | 2026-04-08 |
| Mechanisms for Activation of Beige Adipose Tissue in Humans Placebo, Mirabegron, Mirabegron 50 MG - PreDiabetes | Phase 2 | Recruiting | Philip Kern | 65 | 2020-12-07 | 2026-07-07 |
| Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP Solifenacin 5Mg, Mirabegron 50 MG - Overactive Bladder Syndrome | Phase 2 | Unknown | Buddhist Tzu Chi General Hospital | 130 | 2018-08-01 | 2018-08-24 |
Urinary Bladder, Overactive (2) · Diabetes Mellitus (1) · Platelet Glycoprotein IV Deficiency (1) · Postural Orthostatic Tachycardia Syndrome (1) · Prediabetic State (1) · Syncope (1)
Buddhist Tzu Chi General Hospital (1) · Cedars-Sinai Medical Center (1) · Philip Kern (1) · Seoul National University Hospital (1)
United States (2) · South Korea (1) · Taiwan (1)
Hann-Chorng Kuo, M.D. (1) · Kwanjin Park, MD/PhD (1) · Philip Kern, MD (1)
R01DK124626 (1)